ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

Small But Valued NIH Grant Program Cut In FY92 Budget

April 12, 1991

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

Nixon to Receive ACCC Annual Award

January 10, 1986

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

April 1, 1994